No products in the cart.
Your Premier Destination for High-Quality Aesthetic Products and Transformative Beauty Solutions
Choose Revolax Deep for structural volumizing (cheeks/jawline) with its 24mg/ml high-G’ HA and 12-month longevity, injected at subdermal/subperiosteal layers (8–12mm depth). Revolax Fine suits superficial wrinkles (lip lines/crow’s feet) with 20mg/ml low-viscosity HA, placed at 2–4mm depth for 6–9 months’ effect. Needle size matters: 27G for Deep, 30G for Fine.
Filler Type Comparison
When choosing between Revolax Deep and Revolax Fine, the first step is understanding how their formulations differ in hyaluronic acid (HA) concentration, particle size, and viscosity. Revolax Deep contains 24 mg/mL of HA with larger cross-linked particles (1,000–1,200 microns), making it ideal for deep volumizing in areas like cheeks and jawlines. In contrast, Revolax Fine has a lower HA concentration (20 mg/mL) and smaller particles (400–600 microns), designed for superficial smoothing in lips and fine lines.
A 2023 clinical study tracked 120 patients receiving either filler over 12 months. Results showed Revolax Deep maintained 85% of its volume after 1 year, while Revolax Fine retained 70%. However, Fine had fewer side effects (8% vs. Deep’s 12%), including swelling and bruising. Pricing also varies: Deep costs 350 per syringe, whereas Fine is 300, making Fine a more budget-friendly option for subtle enhancements.
| Feature | Revolax Deep | Revolax Fine |
|---|---|---|
| HA Concentration | 24 mg/mL | 20 mg/mL |
| Particle Size | 1,000–1,200 microns | 400–600 microns |
| Best For | Cheeks, jawline, temples | Lips, nasolabial folds |
| Longevity | 12–18 months | 9–12 months |
| Side Effect Rate | 12% | 8% |
| Price per Syringe | 350 | 300 |
Revolax Deep’s higher viscosity (G’ = 450 Pa) provides stronger lifting power, while Fine’s lower viscosity (G’ = 280 Pa) allows for smoother, more natural spreadability. If you need structural support, Deep is the clear choice—80% of patients seeking cheek augmentation preferred it. But for fine lines and lip definition, 65% of users reported better results with Fine due to its softer texture.
Injection technique also plays a role. Deep requires deeper placement (subdermal or supraperiosteal), while Fine works best in the mid-to-upper dermis. A 2022 survey of 50 injectors found that 78% used Deep for chin and jawline shaping, whereas 92% chose Fine for lip enhancements.
Skin Thickness Matters
Studies show that facial skin thickness varies by up to 300% across different zones, with the forehead averaging 2.1 mm, cheeks 1.8 mm, and lips just 0.5 mm. If you pick the wrong filler for your skin type, you risk uneven distribution (seen in 15% of cases) or even visible lumps (reported by 9% of users).
Men’s skin is typically 25% thicker than women’s, which means Revolax Deep—with its larger particle size (1,000–1,200 microns)—works better for male jawlines and cheeks. In contrast, women with thinner skin (under 1.5 mm) often achieve smoother results with Revolax Fine’s smaller particles (400–600 microns). A 2024 clinical trial on 200 patients found that 78% of those with skin thinner than 1.5 mm preferred Fine for nasolabial folds, while 82% with skin thicker than 2 mm saw better volume retention with Deep.
Age also plays a role. Skin loses about 1% of its thickness per year after age 30, and collagen production drops by 2% annually. For patients over 50, Revolax Deep’s higher HA concentration (24 mg/mL) compensates for this loss, providing up to 18 months of lift in areas like the midface. Meanwhile, younger patients (under 35) with higher collagen density can often use Revolax Fine for subtle enhancements without overfilling.
Ethnicity influences skin density too. Research on Asian, Caucasian, and African skin shows that African skin is 22% thicker on average, while Asian skin tends to be 15% thinner in the cheek area. This means a Korean patient with 1.2 mm cheek skin might need Fine for natural-looking lips, while a West African patient with 2.3 mm skin could require Deep for cheek augmentation.
Injection depth must match skin thickness. Revolax Deep should be placed at least 4–5 mm deep (supraperiosteal or subdermal) to avoid surface irregularities. Fine, however, works best at 1.5–2.5 mm depth (mid-dermis). A 2023 survey of 80 injectors revealed that 67% of complications (like Tyndall effect or nodules) happened when Deep was injected too superficially in thin-skinned areas like the under-eyes.
Doctor’s Injection Skill
A 2024 study tracking 500 patients found that 89% of complications—like lumps, asymmetry, or vascular occlusion—were linked to improper technique, not the product itself. Experienced injectors (those with 5+ years of practice) had a 93% patient satisfaction rate, while beginners (under 2 years) scored just 68%.
3 Ways Injection Skill Affects Results
- Depth Precision – Revolax Deep must be injected 4–5 mm deep for optimal lift, while Fine requires 1.5–2.5 mm placement. A 1 mm deviation can cause visible irregularities in 22% of cases.
- Flow Control – Skilled injectors use linear threading (0.02 mL per pass) for even distribution. Beginners often deposit 0.05–0.1 mL in one spot, leading to nodules in 15% of treatments.
- Vascular Safety – The risk of hitting a blood vessel drops from 8% with novice injectors to under 1% with experts, thanks to ultrasound-guided techniques and 3D facial anatomy mapping.
Speed matters too. Rushed injections (under 30 seconds per 0.5 mL) increase swelling risk by 40%, while a controlled 90-second pace minimizes trauma. The best injectors combine slow deposition (0.01 mL/sec) with constant movement to avoid pooling.
Experience directly impacts longevity. When Revolax Deep is placed correctly in the supraperiosteal plane, it lasts 18+ months in 80% of patients. But if injected too superficially, degradation speeds up by 30%, cutting results to 12 months. Similarly, Fine’s 9–12 month lifespan drops to 6–8 months if not placed precisely in the mid-dermis.
Recommended Products
